HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesAnabasine
Chemical structure of CAS 494-52-0

Anabasine

In Stock•Starting at $54 for 25 mg•Purity ≥ 98%
CAS No.494-52-0
MDL No.MFCD00871391
MFC10H14N2
MW162.23
InChI KeyMTXSIJUGVMTTMU-JTQLQIEISA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
25 mg98%$54In Stock
50 mg98%$66In Stock
100 mg98%$108In Stock
250 mg98%$205In Stock
1 g98%$493In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

(S)-Anabasine is the enantiomer of anabasine.

CAS No.494-52-0
Product NameAnabasine
Acute ToxicAcute Toxic
IrritantIrritant
Health HazardHealth Hazard
Environmental HazardEnvironmental Hazard
Signal Word:Danger
HCode:H300-H301-H310-H315-H319-H361-H411-H227-H371
PCode:P203-P262-P264-P264+P265-P270-P273-P280-P301+P316-P302+P352-P305+P351+P338-P316-P318-P321-P330-P332+P317-P337+P317-P361+P364-P362+P364-P391-P405-P501-P210-P260-P308+P316-P370+P378-P403

Related Articles

Studies related to this compound and its mechanism of action

Piperidine, pyridine alkaloid inhibition of fetal movement in a day 40 pregnant goat model.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association • Vol. 58 • 2013
PMID: 23603380DOI: 10.1016/j.fct.2013.04.009

Effect of α₇ nicotinic acetylcholine receptor agonists and antagonists on motor function in mice.

Toxicology and applied pharmacology • Vol. 266, Issue 3 • 2013
PMID: 23219611DOI: 10.1016/j.taap.2012.11.024

The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats.

The international journal of neuropsychopharmacology • Vol. 12, Issue 10 • 2009
PMID: 19366487DOI: 10.1017/S1461145709000273

Coaxing a pyridine nucleus to give up its aromaticity: synthesis and pharmacological characterization of novel conformationally restricted analogues of nicotine and anabasine.

Journal of medicinal chemistry • Vol. 47, Issue 27 • 2004
PMID: 15615518DOI: 10.1021/jm049707c

Documentation

Similar Products